Ayurvedic treatment for vitiligo

Ayurveda has treated white-patch skin disease (shwitra or kilasa) for centuries, and some people choose to include it in their care. An honest picture of where it may help - and its real risks - matters here.

What classical Ayurveda offers. Treatment frameworks typically combine internal herbal preparations, dietary rules, and external applications, most famously bakuchi (Psoralea corylifolia), a plant containing psoralens - the same class of compounds modern medicine uses in PUVA phototherapy. This historical parallel is interesting, but psoralens work by making skin exquisitely light-sensitive.

The critical safety point about bakuchi. Applying bakuchi oil or paste and then sunning the skin can cause severe burns, blistering and darker staining of surrounding skin - and injury itself can trigger new vitiligo patches (the Koebner phenomenon). Unsupervised bakuchi use is a genuine cause of harm. If used at all, it belongs under a qualified practitioner who controls dose and sun exposure precisely, with your dermatologist informed.

What evidence supports: rigorous clinical trials of Ayurvedic treatment for vitiligo are limited. Some patients report partial repigmentation; controlled evidence is not strong enough to recommend it as a stand-alone treatment, and claims of guaranteed cure should be treated as a red flag.

Sensible integration: Ayurvedic dietary and lifestyle support can accompany modern treatment; what it should not do is delay or replace phototherapy and medical care during the early, most treatable phase. Months spent on herbs alone can cost the window when repigmentation is most achievable.

Ayurvedic view (interpretive): classical texts attribute shwitra to dosha imbalance and treat with shodhana (purification), bakuchi and diet rules - a traditional interpretive framework with limited modern evidence. Adjunct at most, with strict safety supervision, never a substitute for dermatology care.

Remember: bakuchi is a real photosensitizer - burns and new patches are documented harms of careless use. If you combine systems, keep both practitioners informed and never trade away the early treatment window.